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Background and Objectives: In a previous conducted study functional outcome of young patients
with bone sarcoma located around the kneewas longitudinally evaluated during the first 2 years
postoperatively. Functional outcome improved significantly over the first 2 years. The purpose
of this descriptive study was to evaluate the functional outcome of these patients at long-term
follow-up of 7 years.
Methods: Functional outcome was assessed with the TESS, MSTS, Baecke questionnaire, and
three functional performance tests: time up and down stairs (TUDS), various walking activities
(VWA), and the 6-min walking test (6MWT). Linear Mixed Model has been employed for the
repeated measurements.
Results: Twenty patients of the original study (n=44) participated in the current study. Fifteen limb-
salvage and five ablative surgery patients, median follow-up 7.4 years (6.8-8.0) (CI 95%), mean age
22.3 years (18.2-31.6). Between 2 and 7 years after surgery, 8 limb-salvage patients (53%)
encounteredsurgery relatedcomplications.Questionnairesandfunctionalperformancetestsshowed
no significant difference in functional outcome between 2 years and 7 years after surgery P<0.05.
Conclusions: Between 2 years and follow-up at average 7 years after surgery no further
improvements were noticed at young patients with a bone sarcoma located around the knee.
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1 | INTRODUCTION
The most common bone sarcomas in children younger than 20 years
old are osteosarcoma (OSA) (60%) and Ewing sarcoma (ESA) (34%),
about 5% of all pediatric cancers.1,2 The most common localization of
these sarcomas is for the lower extremity the region around the
knee.2,3 In general bone sarcoma are treated in a standard strategy,
namely neoadjuvant chemotherapy, local excision, followed by
adjuvant chemotherapy. Currently the 5-year overall survival rate is
approximately 70% for patients diagnosed with primary non-
metastatic extremity OSA and ESA.4–6 However, the prognosis for
patients with metastatic OSA or ESA at presentation is poor with a 5-
year event-free survival (EFS) of less than 30%.6–8
Since there are no differences in survival rates between limb-
salvage (LS) and ablative surgery (AS), long-term functional outcome
studies have become increasingly important to make a patient specific
surgical decision.9,10 However, comparability of these studies is
complicated because of the use of different research design, different
kind of functional tests and questionnaires, various anatomic sites, a
wide range of ages and follow-up.10–18
In a previous multicenter study by Bekkering et al, functional
ability and physical activity levels were prospectively evaluated at six
This is an open access article under the terms of the Creative Commons
Attribution-NonCommercial License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited and
is not used for commercial purposes.
© 2017 The Authors Journal of Surgical Oncology Published by Wiley
Periodicals, Inc.
J Surg Oncol. 2017;9999:1–5 wileyonlinelibrary.com/journal/jso | 1
time points during 2 years after surgery for malignant bone tumors
around the knee in a cohort of young patients. Surgery consists of
endoprosthesis or allograft reconstruction (LS), rotationplasty, or
amputation (AS). After significant improvement of functional outcome
over the 1st year, it stabilizes over the 2nd year.19
Aim of this long-term follow-up study was to reassess patients of
the original cohort in order to evaluate functional outcome at average
7 years after surgery.
2 | PATIENTS AND METHODS
This long-term follow-up study was an extension of a prospective
multi-center follow-up study conducted between January 2004 and
January 2008.19 Patients who underwent a surgical intervention due
to a bone sarcoma around the knee joint were evaluated in one of
three appointed university medical hospitals in the Netherlands (34 at
Leiden University Medical Centre, 8 at Academic Medical Center
University of Amsterdam and 2 at Erasmus MC University Medical
Center—Sophia Children’s Hospital Rotterdam). All patients (n = 44, 17
female, mean age 15.2 [range 7.8-24.1]) were treated conforming to
EURAMOS-, EORTC/EOI-80931, or Euro-EWING protocol. None of
the patients with an Ewing sarcoma received radiation.
All survivors of the original studywere invited once for the follow-
up study at average 7 years after surgery. Inclusion criteria for the
initial and follow-up study were: (1) age between 8 and 25 years at the
time of surgery, (2) bone sarcoma (osteosarcoma or Ewing sarcoma)
located around the knee, (3) limb-salvage or ablative surgery. Patients
were excluded if medical conditions other than bone tumor (related)
surgery limited their physical activities.
Measurementsat2yearsaftersurgerywereusedascomparisonvalues
for the current follow-up study. Two years after surgery, at the end of the
initial study, 24 patients (15 LS and 9 AS) continued to be monitored.
The Medical Ethics Committee of all three centers approved the
extension of the initial study and all patients gave informed consent.
Patients’ baseline socio-demographic and clinical characteristics,
orthopedic and oncological complications during this long-term
follow-up were derived from the medical record.
Twenty-one patients (48%) had died of disease (DOD). At
diagnosis of the primary bone tumor of the leg 1 patient had also a
bone metastasis and 8 patients had lung metastases. Five years after
surgery the survival rate of all patients was 52.3%. Twenty patients,
out of the 44 patients at the initial study, were eligible to evaluate
functional ability and physical activity (Fig. 1).
One surviving patient was excluded in the initial study due to social
andemotional problems, twopatients refused toparticipate in the follow-
up study without a reason. Mean age at evaluation in the current study
was 22.3 years (range 18.2-31.6) and median follow-up was 7.4 years
(range 6.8-8.0) (CI 95%). None of the patients had at the index surgery
(severe) obesity (BMI ≥ 30) or neuro-motor development disabilities.
Physical therapy consists of muscle function training, optimizing
joint mobility, and performing daily activities such as walking and
climbing stairs independently. Subsequently, after 2 years, rehabilita-
tion was mainly dependent on sport and daily activities.
Table 1 presents patients disease characteristics at 2 years after
surgery and at the follow-up study (Table1). In the current study 75%
had an osteosarcoma (15/20) and 25% an Ewing’s sarcoma (5/20).
At last follow-up 15 patients with a limb-salvage procedure (six
intercalary allografts and nine endoprostheses) were reviewed and
five patientswith an ablative procedure (five amputations). All patients
with a rotationplasty of the initial study died of disease.
Functional ability was assessed with the Toronto Extremity
Salvage Score (TESS), functional performance tests and the Musculo-
skeletal Tumor Society score (MSTS). The MSTS score was only
measured at the long-term follow-up.
The functional tests consist of three different activities: (1) the
timed up and down stairs (TUDS) test, measuring the time a patient
takes to walk up and down 10 stairs (seconds), (2) a combination of
FIGURE 1 Flow chart showing the number of patients in the
original study and the follow-up study
TABLE 1 Disease characteristics at 2 years postoperatively (n = 24)
and at current follow-up study (n = 20)
At 2 years FU At 7 years FU
All patients; n = 24 All patients; n = 20
Surgery
Allograft 6 6
Prosthesis 12 9
Amputation 5 5
Rotationplasty 1 0
Pathology
Osteosarcoma 19 15
Ewing’s sarcoma 5 5
Localization
Distal femur 14 11
Proximal tibia 10 9
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three various walking activities (VWA) consisting of 10m walking at
normal speed, slalom, and obstacle walking, and (3) the 6min walking
test (6MWT); patientswere informed towalk during 6min to cover the
largest distance (meters). Physical activity was assessed with the
Baecke questionnaire, measuring physical activity during sport, leisure
time, and work. The total activity score is the summation of these
items, ranging from 3 (inactive) to 9 (very active).20 Information about
daily living concerning study, work and sportive limitations were
derived from a subject interview. Complications were classified
according to Henderson (H type I-V).21,22
All analyses have been performed with SPSS statistics 20.0 for
Windows (SPSS Inc., Chicago, IL). Level of statistical significance was
set at P < 0.05. A linear mixed model for the repeated measures with
subjects as random effects has been employed to assess the effect for
all patients on functionality measured by all the functional ability tests.
3 | RESULTS
Between 2 years and the current follow-up nine patients encountered
surgery related complications (45%), 3/6 allograft patients, 5/9
prostheses patients, and 1/5 amputation patients. The allograft
complications consisted of a delayed union (H type II, n = 1), a fracture
(H type III,n = 1), andan infection (H type IV,n = 1). The fracture resulted
in a non-union ofmore than 1 year andwas completely healed after two
operations. The infection was healed after two operations.
Theprosthesis complications consistedof aseptic loosening (H type
II, n = 2) and structural failure (H type III, n = 3) and resulting to seven re-
operations (twopatients twice).Oneof the five amputationpatients had
an infection after osseo-integration surgery. None of the included
patients of the follow-up study had local recurrences (H type V).
Functional ability assessed with TESS, MSTS, and functional
performance tests are displayed in Table 2. The TESS scores at 2 years
and 7 years after surgery; 88.1-93.2, TUDS; 11.3-10.9 s, VWA; 25.4-
25.2 s and the 6MWT; 495-514m. The Baecke outcome score
reached a plateau phase after 2 years (7.8-7.8). All changes based on
adjusted estimatedmarginal means between 2 years and 7 years study
were not significant (Table 2).
The MSTS score was 83% (range 37-100%) at 7 years postopera-
tively. The lowest score concerns the domain “walking pattern” (mean
3.8, range 0-5 points) and the highest score at the domain “use of
supports” (mean 4.4, range 0-5 points).
Based on the interviews; 19 patientswere activewith study, work,
or both. Ten patients were involved in a relationship and four of them
became parent. Four patients (3 LS and 1 AS) encountered limitations
of the operated limb during work and/or study. Eleven patients were
active in sports, mainly individual and all low intensive sports, such as
fitness, swimming, or biking. Seven of them changed their sport and
nine of them suffered limitations compared to their peers.
4 | DISCUSSION
The improvements in functional outcome, after surgery due to bone
sarcoma around the knee, between 2 and 7 years follow-up study are
insignificant.
The current study with a 7 years follow-up is an extension of a
previous conducted study of young patients (between 8 and 25 years
old) and in contrast to other longitudinal studies, concerning functional
outcome, without exclusion of patients with local recurrences or
metastasis, using the same outcome measures.19
The small number of reviewed patients has limited the results and
conclusion of the current study. Unfortunately half of the patients at
initial study enrolment deceased on disease.
Physical therapy consists ofmuscle function training, optimizing joint
mobility, andperformingdailyactivities suchaswalkingandclimbingstairs
independently. Subsequently, after 2 years, rehabilitation was mainly
dependent on the individual daily activities and sport activities.
In literature long-term bone sarcoma studies, especially longitu-
dinal prospective studies concerning the functional outcome after limb
surgery for bone sarcoma are scarce. In the prospective study of
Marchese et al a comparable cohort of patients was assessed at 6, 12,
and 18 months after surgery but with different outcome measures
(Functional Mobility Assessment [FMA]), no long-term follow-up and
not comparable to the current study.23
Most studies on this topic have a cross sectional design.
Furthermore, comparability of these long-term studies is hampered
because of different research design (most commonly retrospective
design), use of different outcome measures, widely ranged ages of
included patients and widely ranged follow-up moments.10–12,14–18
TABLE 2 Adjusted estimatedmarginal means (95% confidence intervals [CI]) at 2 and 7 years after surgery and mean difference (95% confidence
intervals [CI]) between 2 and 7 years after surgery
Estimated means (CI) Mean differences (CI)
2 years 7 years 2-7 years P-value
TESS 88.1 (83.1-93.1) 93.2 (88.0-98.6) −5.2 (−10.9-0.5) 0.08
6MWT 494.6 (456.2-533.0) 513.5 (470.9-556.1) −18.9 (−68-30.2) 0.45
TUDS 11.3 (7.1-15.5) 10.9 (6.2-15.6) 0.4 (−5.2-6.0) 0.89
VWA 25.4 (22.0-28.7) 25.2 (21.6-28.8) 0.2 (−3.6-4.0) 0.94
BAECKE 7.8 (7.3-8.4) 7.8 (7.3-8.4) 0,0 (−0.6-0.6) 0.96
MSTS 83 (37-100)
TESS, Toronto Extremity Salvage Score; 6MWT, 6minwalking test; TUDS, timed up and down stairs; VWA, variouswalking activity;MSTS,Musculo-Skeletal
Tumor Society score.
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In general, studies focusing on functional outcome after bone
sarcoma surgery of the lower limb, report outcome scores of TESS and
MSTS most commonly.12,14,15,18
The prospective study of Ginsberg et al which is most comparable to
the present study concerning age and follow-up time points, reported
similarTESSscoresat5yearspost-surgery: amedian follow-updurationof
5.6 years, mean age at surgery of 14.5 years (sd = 4.06) and mean age at
study enrollment of 20.1 years (sd = 5.7). TESS scores of amputations
above the knee 84.4 (sd = 10.8), amputations below the knee 94.5
(sd = 5.1), LS femur 94.5 (sd = 9.9), and LS tibia 88.1 (sd = 9.3) are
comparable to the current study.14 The MSTS scores in the study of
Ginsbergofamputationabove-belowknee;65-77%andLS femur-LS tibia;
73-77%; however, are below the scores of the current study (83%).14
According Pakulis et al the MSTS do not meet any of the
components for sensibility for the pediatric bone tumor population,
despite the popularity of the MSTS scales.24
Unfortunately a number of studies concerning bone sarcoma
surgery of the lower extremity reporting scores of TESS andMSTS are
not comparable to the current study. The studies by Hopyan et al and
Aksnes et al report on older patients, respectively mean 26 years
(range 10-39 years) and 31 years (range 15-57 years) and a longer
median follow-up duration respectively mean 13,9 (range 5-26 years)
and 13 years (range 6-22 years).12,15
Additionally, in the study byAkahane et al lacked allograft patients
and in the study by Saraiva et al only endoprosthesis and amputation
patients were included.11,17
In the end comparison of all these studies with the current follow-
up study at 7 years postoperatively is laborious because of the
difference in age, difference in timeframe and distribution in respect of
surgery of the included patients.
Physical activity as part of the functional outcome was measured
by the Baecke questionnaire. Van Dam et al, using the Baecke
questionnaire, reported outcome scores of 7.0 (range 4.2-8.6) for
patients after bone sarcoma surgery 2 years post-surgery.18 Although
these comparable scores, the high median age of the included patients
(49 years, range 18-69) and the wide range in follow-up (range 1-13
years) limited the comparability to our results.18
Functional outcome scores in longitudinal studies of patients after
malignant bone surgery are mostly derived frommeasurements such as
TESS, Baecke, andMSTS. These questionnaires report on the individual
perception and satisfaction of physical activity and functional ability
after anoperation andespecially after surviving a life-threatening event.
Scores derived from functional tests, consisting of daily life
activities, are more objective compared to questionnaires. Short- and
long-term functional test scores, could be helpful to more accurately
predict functionality after limb surgery. However, despite their
objectivity, patients with the same functional outcome could have
different perception and satisfaction after the same surgery according
questionnaires concerning functional outcome.
Only a few studies regarding functional outcome after bone
sarcoma surgery, report about objective functional tests.23,25 In
contrast, the current study contains both kind of data collection and
additionally we also measured functional outcome at short- and long-
termwith the same research design and the samemeasure instruments.
Unfortunately, nearly half of the patients dead of disease and the
survival of 23 patients (52,3%) in the current follow-up study is lower
than the described 70% survival rate in the literature.4,26 This could be
due to the fact that at initial study enrolment 9 of the 44 patients had
bone or lung metastases at first surgery.
The functional outcome stabilizes after 2 years, which was
remarkable given the number of complications in the follow-up. The
high complication and revision rate of the endoprostheses (5/9
patients, 55%), between 2 years after surgery and current study are
not in line with the result of studies of Capanna et al, reporting an
overall implant survival rate of and 75,9 % at 5 years and 66,2% at
10 years. However, in the study of Capanna et al age of the included
patients varied widely (mean 43 years, range 12-90 years).27 A higher
activity level of the younger patients in the current follow-up study
induces probably this higher complication rate.
Remarkable, between 2 and 7 years after surgery there is no
deterioration in performance despite the fact that half of the patients
had one or more complications. It would be interesting to evaluate
whether age, chemotherapy and/or type of reconstruction influence
functional outcome scores in a subsequent larger cohort study.
Despite these surgical complications, all patients covered a longer
walking distance in the current study. However, outcome scores at the
current follow-up study of 514 meter (range 471-556) are still lower
compared to outcome score of 593 meters ± 57 at healthy subjects
between 20 and 50 years old.28
There were no significantly changes concerning the TUDS
between the original study and the current study. However, it is not
possible to compare these values with normal values, since there is no
standard design for the TUDS and normal values are missing as a
result.29
Despite the encountered complications and stabilization of the
improvement in functional outcome in the first 2 years after surgery,
these constraints are not limiting for age-appropriate social participa-
tion at work, sport, and school. All patients in the current study at
7 years postoperatively are working and/or studying and participating
in sports.
Based on our results we postulate that 2 years after surgery
patients reach a stable phase and cope with their minor disabilities.
They are able to integrate themwell into normal life despite functional
impairments.
Concerning the small cohort size, we recommend a prospective
study with a larger cohort to confirm our conclusion regarding
functional outcome and surgical treatment.
5 | CONCLUSION
We found no significant difference in functional outcome concerning
TESS, Baecke, 6min walking distance test and functional tests (TUDS,
VWA) between 2 years and 7 years after surgery in patients treated for
bone sarcoma around the knee.
After a significant improvement in functional outcome during the
first year after resection of the bone sarcoma, the functional outcome
stabilizes and no improvement was found 7 years after surgery.
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